Predictive model for vedolizumab efficacy in moderate-to-severe ulcerative colitis based on computed tomography-derived body compositions and nutritional inflammatory markers

Read full text Summarise with VIRAT
Authors: Xiao-Yan Zhang, Yu-Kun Li, Zi-Bin Tian, Qing-Yu Guo, Jingnong Liu, Rui-Qing Liu, Ke-Yu Ren
Cited by: 0
References: 43

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND Vedolizumab (VDZ) is a key biologic for moderate-to-severe ulcerative colitis (UC), but therapeutic response varies widely among patients. The combined predictive value of computed tomography (CT)-derived body composition (e.g. , intramuscular adipose tissue, skeletal muscle mass), inflammatory markers [C-reactive protein (CRP)], and anemia status for VDZ efficacy remains under-investigated. AIM To develop a predictive model for VDZ response in moderate-to-severe UC patients, based on CT-derived body composition and nutritional/inflammatory markers, and to clarify their clinical implications. METHODS A retrospective study was conducted on UC patients treated with VDZ at the Affiliated Hospital of Qingdao University. CT images were analyzed to quantify intramuscular adipose tissue and skeletal muscle mass. Clinical data including CRP levels and hemoglobin (HB) were collected. Multivariate logistic regression was used to identify independent predictors of treatment response, and a predictive model was constructed. RESULTS IMAT accumulation (odds ratio = 2.35, 95% confidence interval: 1.21-4.57, P = 0.012) and elevated CRP (odds ratio = 1.89, 95% confidence interval: 1.03-3.49, P = 0.041) were confirmed as independent predictors of poor VDZ response. Preserved skeletal muscle mass and normal HB levels were associated with better therapeutic outcomes. The combined predictive model demonstrated good discriminative ability (area under the curve = 0.78). CONCLUSION This study demonstrates that CT-derived body composition parameters (IMAT and skeletal muscle mass), combined with inflammatory markers (CRP) and HB levels, can effectively predict VDZ response in UC patients. The predictive model we developed offers a practical tool for identifying high-risk non-responders early, enabling clinicians to optimize individualized treatment strategies and improve clinical outcomes.

Fields of Study & Subjects

Inflammatory Bowel Disease Rheumatoid Arthritis Research and Therapies Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
World Journal of Radiology
Volume
18
Issue
3
Pages
117599–117599
Publication date
26 March 2026
Language
EN